1[1]Friedel HA, Goa KL, Benfield P. Focus on S-adenosyl-L-methionine. Drugs, 1989, 38:389
2[2]Bortolini M, Almasio P, Bray G, et al. Multicentre survey of the prevalence of intrahepatic cholestasis in 2520 consecutive patients with newly diagnosed chronic liver disease. Drug Invest, 1992, 4(suppl 4): 83
3[3]Catalino S, Scarponi S, cesa F, et al. Efficacy and Safety of inravenous S-adenosyl-L-methionine in the mangement of intrahepatic cholestasis of pregnancy. Drugs invest, 1992, 4 (suppl 4): 78
4[4]Watson WH, zhao Y, Chawla BK S-adenosylmethionine attenuates the lipopolysaccharide-induced expression of the gene for tumour necrosis factor aplha. BiochemJ, 1999, 342: 21
2Ware JE,Jr Kosinski M,Bayliss MS,at al. Comparison of methods for the scoring and statistical analysis of SF - 36 health profile and summary measures: Summary of results from the Medical Out comes Study[J:. Med Care, 1995,33(4 Suppl) : AS264 - 279.
3Ware JE, Jr Kosinski M, Bayliss MS, et al. Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures:Summary of results from the medical outcomesstudy[ J ]. Med Care, 1995,33 (4 Suppl) : AS264-AS279.
